Sponsor:
University of Tennessee
Code:
NCT03560362
Conditions
Pain, Postoperative
Lung Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Bupivacaine liposome
Bupivacaine / Epinephrine
Brief summary:
Conditions
Pain, Postoperative
Lung Cancer
Study ID
NCT03560362
Start date
Jul 9, 2015
Status verified date
Jun, 2018
Completion date
Oct 31, 2018
Anticipated
Primary completion date
Oct 31, 2018
Anticipated
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Enrollment
50 participants
Anticipated
Allocation
Randomized
Intervention Model
Parallel Assignment
Primary purpose
Treatment
Arms
active comparator: Bupivacaine with epinephrine
experimental: Lipossomal extended release bupivacaine
Interventions
Bupivacaine liposome
Bupivacaine / Epinephrine
Primary outcome measure
Central contacts
Locations
Methodist University Hospital
Recruiting
Memphis, Tennessee, United States, 38104
Contacts
Sponsor
University of Tennessee
Last update posted
Jun 20, 2018
Last verified
Jun, 2018
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by University of Tennessee on 2018-06-20.